High Pointe Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,400
Closed -$1.23M 83
2020
Q1
$1.23M Buy
+5,400
New +$1.47M 1.75% 23

Other funds holding ELV

High Pointe Capital Management's ELV Position: Q2 2020 in Review

High Pointe Capital Management sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 5,400 shares — an estimated $1.23M sold.

High Pointe Capital Management first reported a position in ELV in Q1 2020 and held it in 1 quarter. The position peaked at $1.23M in Q1 2020. 1,106 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

  • High Pointe Capital Management reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
  • High Pointe Capital Management sold 5,400 Elevance Health shares in Q2 2020, an estimated $1.23M.
  • High Pointe Capital Management first reported a position in Elevance Health in Q1 2020 and held it in 1 quarter.
  • High Pointe Capital Management's Elevance Health position peaked at $1.23M in Q1 2020.
  • 1,106 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on High Pointe Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.